Phagelux Announces Acquisition of Novel Delivery Systems

SHANGHAI, Dec. 23, 2014 /PRNewswire/ -- Phagelux, Inc., a leading anti-bacterial company developing phage-based solutions, is pleased to announce the acquisition of several biodegradable polymer delivery systems from Iveria Technologies, Inc., a U.S.-based development company specializing in such technologies. 

"The acquisition of these technologies from Iveria will allow us to deliver our phage-based antibacterial solutions either as stand-alone products or in combination with more established medicines," said Mark Engel, Chairman of Phagelux.  "The latter should open up a series of licensing and co-development opportunities for our company." 

About Phagelux, Inc.

Phagelux, Inc. is developing anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies.  Phagelux is headquartered in Shanghai, with laboratories in China and North America.

Media Contact

Dr. Sixiang Zhou
Director of Business Development
+86-21-6150-0300
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/phagelux-announces-acquisition-of-novel-delivery-systems-300013532.html

SOURCE Phagelux, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED